Incidence of acute ischaemic heart disease in Plzen
Simon, J.; Svojgrová, M.
Review of Czechoslovak Medicine 21(1): 26-34
1975
ISSN/ISBN: 0034-6497 PMID: 1121598 Document Number: 90611
Document emailed within 1 workday
Related Documents
Craig, I.H.; Byrne, E.; Tiltman, R.C. 1978: Changing mortality from ischaemic heart disease and acute myocardial infarction Medical Journal of Australia 2(10): 461-464Oganov, R.G.; Zhukovskii, G.S.; Glasunov, I.S.; Perova, N.V.; Chakhava, M.V.; Deev, A.D.; Konstantinov, V.V.; Akhmeteli, M.A.; Vinogradova, D.A. 1987: Changes in the incidence of ischaemic heart disease (IHD) risk factors among a male population without IHD aged 40-59 years after eight-year period (from 1975-1977 to 1983-1984) Cor et Vasa 29(6): 406-411
Schäbitz, J.; Krosch, H. 1983: Haemorheological investigations in patients with chronic ischaemic heart disease and acute myocardial infarction Cor et Vasa 25(3): 161-167
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Lakka, H.M.; Lakka, T.A.; Tuomilehto, J.; Sivenius, J.; Salonen, J.T. 2000: Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study Archives of Internal Medicine 160(8): 1160-1168
Golan, D.T.; Kursbaum, A. 1976: Anti-heart autoantibodies in ischaemic heart disease patients Clinical and Experimental Immunology 26(1): 86-90
Munkvad, S. 1993: Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways Danish Medical Bulletin 40(4): 383-408
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Bashir, R.; Khan, A.; Yousaf, M. 1996: Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 46(10): 225-228
Van Assche, F.A.; Aerts, L.; Holemans, K. 1994: Low birthweight and ischaemic heart disease Lancet 343(8899): 731-732
Violi, F.; Iuliano, L.; Iullano, L. 1997: Antioxidants and ischaemic heart disease Lancet 350(9078): 667-668
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Law, M.R.; Wald, N.J. 1999: Homocysteine and ischaemic heart disease Haematologica 84 Suppl Eha-4: 57-60
Wojtczak, A.; Skretkowicz, J. 2007: Genetics in ischaemic heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 5-8
Christie, J. 2011: Ischaemic heart disease prevention NursingTimes 107(30-31): 20
Lhotka, J.; Stuchlíková, E.; Klimesová, A. 1971: Changes in the pericardium in ischaemic heart disease Acta Universitatis Carolinae. Medica 17(7): 573-580
Radic, A.; Dean, G. 1977: Hospitalisation and complications in acute ischaemic heart attacks Irish Medical Journal 70(10): 299-303
Tauheed, S.; Shoaib, S.; Kamal, A. 1993: Haematocrit values in ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 43(2): 34-35
Krishnaswami, S.; Cherian, G. 1980: Ischaemic heart disease nomenclature and definitions Journal of the Association of Physicians of India 28(8): 239-240